
Summary
- L.TO rose slightly over the past 10 trading sessions: C$64.59 on Jun. 15 → C$65.93 on Jun. 26 = +C$1.34 / +2.1%.
- The move was not smooth: it fell to C$63.38 on Jun. 22, then rebounded strongly on Jun. 23–24.
- Main driver: defensive rotation into staples, helped by Loblaw’s stable grocery/pharmacy earnings profile.
- Q1 fundamentals support the stock: revenue +4.2%, Food same-store sales +2.4%, Drug same-store sales +4.1%, adjusted EPS +10.6%.
- Upside is limited by valuation: Yahoo showed P/E ~29x and a 52-week range of C$52.92–C$69.59.
10-Day Price Action
| Date | Close | Daily Move |
|---|---|---|
| Jun. 15 | C$64.59 | -0.63% |
| Jun. 16 | C$64.88 | +0.45% |
| Jun. 17 | C$64.69 | -0.29% |
| Jun. 18 | C$64.76 | +0.11% |
| Jun. 19 | C$64.09 | -1.03% |
| Jun. 22 | C$63.38 | -1.11% |
| Jun. 23 | C$64.77 | +2.19% |
| Jun. 24 | C$66.20 | +2.21% |
| Jun. 25 | C$66.09 | -0.17% |
| Jun. 26 | C$65.93 | -0.24% |
Source: Investing.com historical data.
Why It Moved
1. Defensive rotation
Loblaw benefited when money moved into consumer staples during broader TSX volatility. On Jun. 24, the TSX hit a 13-day low as oil and gold fell, pressuring energy and materials. Staples were relatively attractive because grocery and pharmacy earnings are less cyclical.
2. Fundamentals are steady
Loblaw’s Q1 numbers were strong enough to support the stock:
| Metric | Q1 2026 | Impact |
|---|---|---|
| Retail revenue | C$14.484B, +4.2% | Positive |
| Food same-store sales | +2.4% | Stable |
| Drug same-store sales | +4.1% | Positive |
| E-commerce sales | +20.3% | Positive |
| Retail adjusted EBITDA | C$1.607B, +6.5% | Positive |
| Adjusted EPS | C$0.52, +10.6% | Positive |
| Dividend | +10% | Supportive |
Source: Loblaw Q1 release.
3. Rebound after weakness
The stock dropped from C$65.00 on Jun. 12 to C$63.38 on Jun. 22, then recovered to C$66.20 by Jun. 24. That looks like a short-term mean-reversion bounce, not a new earnings event.
Valuation Logic
| Factor | Impact |
|---|---|
| Defensive grocery/pharmacy earnings | Supports premium valuation |
| Same-store sales positive | Supports trend |
| Buybacks and dividend growth | Supports EPS/share |
| P/E near 29x | Limits upside |
| Close to 52-week high | Profit-taking risk |
Scenarios
| Scenario | Trigger | Price implication |
|---|---|---|
| Bull | Holds above C$66 and staples rotation continues | Retest C$68–70 |
| Base | Stable earnings, valuation caps upside | Range C$64–67 |
| Bear | Profit-taking or weak consumer data | Pullback toward C$63–64 |
Actionable Takeaways
L.TO’s 10-day move was a modest defensive-sector rebound. The stock recovered after a dip because Loblaw has stable grocery/pharmacy earnings, positive same-store sales, buybacks, and dividend growth. The main constraint is valuation: at roughly 29x earnings, further upside needs continued earnings growth, not just defensive rotation.
Leave a Reply
You must be logged in to post a comment.